Cti Biopharma reported $0 in Sales Revenues for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Applied Genetic Technologies AGTC:US $ 0.5M 0.5M
Baxter International BAX:US $ 3098M 152M
Bristol Myers Squibb BMY:US $ 11703M 630M
Cytori Therapeutics CYTX:US $ 0M 0M
Eli Lilly And LLY:US $ 6740.1M 65.5M
Geron GERN:US $ 0.11M 0.03M
Mirati Therapeutics MRTX:US $ 0M 0M
Northwest Biotherapeutics NWBO:US 416K 177K
Novartis NVS:US $ 13294M 600M
Novartis NOVN:VX SF 13294M 600M
Seattle Genetics SGEN:US $ 388.48M 56.5M
Teva Pharmaceutical Industries TEVA:US $ 3910M 72M
YTE INCY:US $ 705.71M 100.99M